热门资讯> 正文

AN2 Therapeutics GAAP EPS—0.57美元击败0.17美元

2024-03-29 18:57

AN2 Therapeutics press release (NASDAQ:ANTX): Q4 GAAP EPS of -$0.57 beats by $0.17.
The Company had cash, cash equivalents, and investments of $134.5 million at December 31, 2023.

More on AN2 Therapeutics

Spotlight On Nvidia, Walmart, Palo Alto Networks And CAGNY Conference
AN2 Therapeutics reports FY results
AN2 Therapeutics extends losses as Leerink cuts on trial setback
Seeking Alpha’s Quant Rating on AN2 Therapeutics
Historical earnings data for AN2 Therapeutics

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。